Cargando…

The dopamine D1 receptor agonist SKF81297 has dose-related effects on locomotor activity but is without effect in a CER trace conditioning procedure conducted with two versus four trials

In an appetitively motivated procedure, we have previously reported that systemic treatment with the dopamine (DA) D1 receptor agonist SKF81297 (0.4 and 0.8 mg/kg) depressed acquisition at a 2 s inter-stimulus-interval (ISI), suitable to detect trace conditioning impairment. However since DA is invo...

Descripción completa

Detalles Bibliográficos
Autores principales: Pezze, M.A., Marshall, H.J., Cassaday, H.J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academic Press 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4974238/
https://www.ncbi.nlm.nih.gov/pubmed/27524835
http://dx.doi.org/10.1016/j.lmot.2016.06.001
_version_ 1782446515644530688
author Pezze, M.A.
Marshall, H.J.
Cassaday, H.J.
author_facet Pezze, M.A.
Marshall, H.J.
Cassaday, H.J.
author_sort Pezze, M.A.
collection PubMed
description In an appetitively motivated procedure, we have previously reported that systemic treatment with the dopamine (DA) D1 receptor agonist SKF81297 (0.4 and 0.8 mg/kg) depressed acquisition at a 2 s inter-stimulus-interval (ISI), suitable to detect trace conditioning impairment. However since DA is involved in reinforcement processes, the generality of effects across appetitively- and aversively-motivated trace conditioning procedures cannot be assumed. The present study tested the effects of SKF81297 (0.4 and 0.8 mg/kg) in an established conditioned emotional response (CER) procedure. Trace-dependent conditioning was clearly shown in two experiments: while conditioning was relatively strong at a 3-s ISI, it was attenuated at a 30-s ISI. This was shown after two (Experiment 1) or four (Experiment 2) conditioning trials conducted in – as far as possible – the same CER procedure. Contrary to prediction, in neither experiment was there any indication that trace conditioning was attenuated by treatment with 0.4 or 0.8 mg/kg SKF81297. In the same rats, locomotor activity was significantly enhanced at the 0.8 mg/kg dose of SKF81297. These results suggest that procedural details of the trace conditioning variant in use are an important determinant of the profile of dopaminergic modulation.
format Online
Article
Text
id pubmed-4974238
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Academic Press
record_format MEDLINE/PubMed
spelling pubmed-49742382016-08-11 The dopamine D1 receptor agonist SKF81297 has dose-related effects on locomotor activity but is without effect in a CER trace conditioning procedure conducted with two versus four trials Pezze, M.A. Marshall, H.J. Cassaday, H.J. Learn Motiv Article In an appetitively motivated procedure, we have previously reported that systemic treatment with the dopamine (DA) D1 receptor agonist SKF81297 (0.4 and 0.8 mg/kg) depressed acquisition at a 2 s inter-stimulus-interval (ISI), suitable to detect trace conditioning impairment. However since DA is involved in reinforcement processes, the generality of effects across appetitively- and aversively-motivated trace conditioning procedures cannot be assumed. The present study tested the effects of SKF81297 (0.4 and 0.8 mg/kg) in an established conditioned emotional response (CER) procedure. Trace-dependent conditioning was clearly shown in two experiments: while conditioning was relatively strong at a 3-s ISI, it was attenuated at a 30-s ISI. This was shown after two (Experiment 1) or four (Experiment 2) conditioning trials conducted in – as far as possible – the same CER procedure. Contrary to prediction, in neither experiment was there any indication that trace conditioning was attenuated by treatment with 0.4 or 0.8 mg/kg SKF81297. In the same rats, locomotor activity was significantly enhanced at the 0.8 mg/kg dose of SKF81297. These results suggest that procedural details of the trace conditioning variant in use are an important determinant of the profile of dopaminergic modulation. Academic Press 2016-08 /pmc/articles/PMC4974238/ /pubmed/27524835 http://dx.doi.org/10.1016/j.lmot.2016.06.001 Text en © 2016 The Author(s) http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Pezze, M.A.
Marshall, H.J.
Cassaday, H.J.
The dopamine D1 receptor agonist SKF81297 has dose-related effects on locomotor activity but is without effect in a CER trace conditioning procedure conducted with two versus four trials
title The dopamine D1 receptor agonist SKF81297 has dose-related effects on locomotor activity but is without effect in a CER trace conditioning procedure conducted with two versus four trials
title_full The dopamine D1 receptor agonist SKF81297 has dose-related effects on locomotor activity but is without effect in a CER trace conditioning procedure conducted with two versus four trials
title_fullStr The dopamine D1 receptor agonist SKF81297 has dose-related effects on locomotor activity but is without effect in a CER trace conditioning procedure conducted with two versus four trials
title_full_unstemmed The dopamine D1 receptor agonist SKF81297 has dose-related effects on locomotor activity but is without effect in a CER trace conditioning procedure conducted with two versus four trials
title_short The dopamine D1 receptor agonist SKF81297 has dose-related effects on locomotor activity but is without effect in a CER trace conditioning procedure conducted with two versus four trials
title_sort dopamine d1 receptor agonist skf81297 has dose-related effects on locomotor activity but is without effect in a cer trace conditioning procedure conducted with two versus four trials
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4974238/
https://www.ncbi.nlm.nih.gov/pubmed/27524835
http://dx.doi.org/10.1016/j.lmot.2016.06.001
work_keys_str_mv AT pezzema thedopamined1receptoragonistskf81297hasdoserelatedeffectsonlocomotoractivitybutiswithouteffectinacertraceconditioningprocedureconductedwithtwoversusfourtrials
AT marshallhj thedopamined1receptoragonistskf81297hasdoserelatedeffectsonlocomotoractivitybutiswithouteffectinacertraceconditioningprocedureconductedwithtwoversusfourtrials
AT cassadayhj thedopamined1receptoragonistskf81297hasdoserelatedeffectsonlocomotoractivitybutiswithouteffectinacertraceconditioningprocedureconductedwithtwoversusfourtrials
AT pezzema dopamined1receptoragonistskf81297hasdoserelatedeffectsonlocomotoractivitybutiswithouteffectinacertraceconditioningprocedureconductedwithtwoversusfourtrials
AT marshallhj dopamined1receptoragonistskf81297hasdoserelatedeffectsonlocomotoractivitybutiswithouteffectinacertraceconditioningprocedureconductedwithtwoversusfourtrials
AT cassadayhj dopamined1receptoragonistskf81297hasdoserelatedeffectsonlocomotoractivitybutiswithouteffectinacertraceconditioningprocedureconductedwithtwoversusfourtrials